1-4 of 4
Kateryna Vilchevska
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis: the ATLAS-PPX trial

Clinical Trials & Observations
Gili Kenet, Beatrice Nolan, Bulent Zulfikar, Bulent Antmen, Peter Kampmann, Tadashi Matsushita, Chur-Woo You, Kateryna Vilchevska, Catherine N. Bagot, Azizan Sharif, Flora Peyvandi, Guy Young, Claude Negrier, Jiarui Chi, Barbara Kittner, Christian Sussebach, Fadi Shammas, Baisong Mei, Shauna Andersson, Kaan Kavakli
Journal: Blood
Blood (2024) 143 (22): 2256–2269.
https://doi.org/10.1182/blood.2023021864
Published: 2024
Includes: Supplemental data
Journal Articles

Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia

Clinical Trials & Observations
Tadeusz Robak, Jerzy Windyga, Jacek Trelinski, Mario von Depka Prondzinski, Aristoteles Giagounidis, Chantal Doyen, Ann Janssens, María Teresa Álvarez-Román, Isidro Jarque, Javier Loscertales, Gloria Pérez Rus, Andrzej Hellmann, Wiesław Wiktor Jêdrzejczak, Kazimierz Kuliczkowski, Lana M. Golubovic, Dusica Celeketic, Andrei Cucuianu, Emanuil Gheorghita, Mihaela Lazaroiu, Ofer Shpilberg, Dina Attias, Elena Karyagina, Kalinina Svetlana, Kateryna Vilchevska, Nichola Cooper, Kate Talks, Mukhyaprana Prabhu, Prasad Sripada, T. P. R. Bharadwaj, Henrik Næsted, Niels J. Ø. Skartved, Torben P. Frandsen, Mimi F. Flensburg, Peter S. Andersen, Jørgen Petersen
Journal: Blood
Blood (2012) 120 (18): 3670–3676.
https://doi.org/10.1182/blood-2012-06-438804
Published: 2012
Journal Articles

Final Results From a Phase II Trial with the First in Class Recombinant Polyclonal Antibody Product Rozrolimupab in Primary Immune Thrombocytopenia

Tadeusz Robak, Jacek Trelinski, Mario von Depka Prondzinski, Aristoteles Giagounidis, Chantal Doyen, MD, Ann Janssens, Mayte Álvarez Román, MD, Javier Loscertales Pueyo, Isidro Jarque Ramos, Javier Loscertales, Gloria Pérez Rus, Andrzej Hellmann, MD, Wieslaw Wiktor-Jedrzejczak, MD, PhD, Kazimierz Kuliczkowski, Lana Golubovic, Dusica Celeketic, Andrei Cucuianu, Emanuil Gheorghita, Lazaroiu Mihaela, Dina Attias, Ofer Shpilberg, MD, MPH, Elena Karyagina, Kateryna Vilchevska, Kalinina Svetlana, Nichola Cooper, MA MD MRCP FRCPath, Kate Talks, Mukyaprana Prabhu, Sripada V.S.S Prasad, T. P. Raghava Bharadwaj, Mimi Folden Flensburg, Jorgen Petersen, MD, PhD, Jerzy Windyga
Journal: Blood
Blood (2011) 118 (21): 527.
https://doi.org/10.1182/blood.V118.21.527.527
Published: 2011
Journal Articles

Pharmacokinetics (PK) and Pharmacodynamics (PD) of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients with Relapsed Multiple Myeloma: Effects of Subcutaneous Injection Site and Concentration, and Patient Characteristics

Philippe Moreau, MD, Ievgenii I Karamanesht, MD, Natalia Domnikova, Maryna Y Kyselyova, MD, Kateryna Vilchevska, Vadim A Doronin, MD, PhD, Alexander Schmidt, MD, Cyrille Hulin, MD, Xavier Leleu, MD, PhD, Dixie-Lee Esseltine, MD, FRCPC, Karthik Venkatakrishnan, Donna M Skee, BS, Huaibao Feng, PhD, Suzette Girgis, Andrew Z Cakana, MD, FRCPath, William M Deraedt, PhD, Thierry Facon, MD
Journal: Blood
Blood (2011) 118 (21): 1863.
https://doi.org/10.1182/blood.V118.21.1863.1863
Published: 2011